SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 239 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4 | -42.9% | 157 | -27.6% | 0.00% | – |
Q1 2024 | $7 | +16.7% | 217 | 0.0% | 0.00% | – |
Q4 2023 | $6 | 0.0% | 217 | 0.0% | 0.00% | – |
Q3 2023 | $6 | -14.3% | 217 | 0.0% | 0.00% | – |
Q2 2023 | $7 | -12.5% | 217 | 0.0% | 0.00% | – |
Q1 2023 | $8 | 0.0% | 217 | 0.0% | 0.00% | – |
Q4 2022 | $8 | -99.9% | 217 | +19.2% | 0.00% | – |
Q3 2022 | $6,000 | +20.0% | 182 | 0.0% | 0.00% | – |
Q2 2022 | $5,000 | -16.7% | 182 | 0.0% | 0.00% | – |
Q1 2022 | $6,000 | +20.0% | 182 | 0.0% | 0.00% | – |
Q4 2021 | $5,000 | 0.0% | 182 | 0.0% | 0.00% | – |
Q3 2021 | $5,000 | +66.7% | 182 | +83.8% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 99 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | +50.0% | 99 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | -66.7% | 99 | -66.6% | 0.00% | – |
Q3 2020 | $6,000 | +20.0% | 296 | 0.0% | 0.00% | – |
Q2 2020 | $5,000 | 0.0% | 296 | 0.0% | 0.00% | – |
Q1 2020 | $5,000 | -28.6% | 296 | 0.0% | 0.00% | – |
Q4 2019 | $7,000 | -22.2% | 296 | -10.8% | 0.00% | – |
Q3 2019 | $9,000 | -18.2% | 332 | 0.0% | 0.00% | – |
Q2 2019 | $11,000 | -8.3% | 332 | 0.0% | 0.00% | – |
Q1 2019 | $12,000 | +33.3% | 332 | +17.3% | 0.00% | – |
Q4 2018 | $9,000 | -35.7% | 283 | 0.0% | 0.00% | – |
Q3 2018 | $14,000 | -17.6% | 283 | 0.0% | 0.00% | – |
Q2 2018 | $17,000 | -99.5% | 283 | -99.6% | 0.00% | -100.0% |
Q1 2018 | $3,159,000 | – | 68,983 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $17,478,000 | 3.94% |
ASHFORD CAPITAL MANAGEMENT INC | 1,124,405 | $36,341,000 | 3.91% |
ARMISTICE CAPITAL, LLC | 3,100,000 | $100,192,000 | 1.94% |
S&T BANK/PA | 316,326 | $10,224,000 | 1.54% |
Bruce & Co., Inc. | 222,105 | $7,178,000 | 1.47% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 379,875 | $12,278,000 | 1.36% |
RICE HALL JAMES & ASSOCIATES, LLC | 854,949 | $27,632,000 | 1.10% |
Soleus Capital Management, L.P. | 251,000 | $8,112,000 | 1.05% |
Parkman Healthcare Partners LLC | 108,954 | $3,521,000 | 1.03% |
Aristotle Capital Boston, LLC | 1,258,067 | $40,661,000 | 1.03% |